Research Analysts’ price target changes for Tuesday, August 4th:
Asbury Automotive Group (NYSE:ABG) had its target price lowered by JPMorgan Chase & Co. from $220.00 to $190.00. The firm currently has an underweight rating on the stock.
Alignment Healthcare (NASDAQ:ALHC) had its price target cut by JPMorgan Chase & Co. from $26.00 to $22.00. They currently have an overweight rating on the stock.
Biogen (NASDAQ:BIIB) had its price target raised by Mizuho from $221.00 to $241.00. They currently have an outperform rating on the stock.
Bank of New York Mellon (NYSE:BNY) had its price target raised by JPMorgan Chase & Co. from $149.00 to $159.00. They currently have an overweight rating on the stock.
Bitdeer Technologies Group (NASDAQ:BTDR) had its price target increased by Needham & Company LLC from $19.00 to $22.00. The firm currently has a buy rating on the stock.
Clorox (NYSE:CLX) had its target price increased by JPMorgan Chase & Co. from $92.00 to $95.00. They currently have an underweight rating on the stock.
Centene (NYSE:CNC) had its price target raised by JPMorgan Chase & Co. from $60.00 to $67.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Crescent Energy (NYSE:CRGY) had its price target boosted by Mizuho from $15.00 to $16.00. Mizuho currently has a neutral rating on the stock.
CVR Energy (NYSE:CVI) had its target price boosted by Mizuho from $28.00 to $29.00. They currently have an underperform rating on the stock.
Harmony Biosciences (NASDAQ:HRMY) had its target price increased by Needham & Company LLC from $45.00 to $50.00. They currently have a buy rating on the stock.
Immunovant (NASDAQ:IMVT) had its price target raised by JPMorgan Chase & Co. from $47.00 to $50.00. They currently have an overweight rating on the stock.
Incyte (NASDAQ:INCY) had its price target raised by Mizuho from $121.00 to $137.00. Mizuho currently has an outperform rating on the stock.
Inspire Medical Systems (NYSE:INSP) had its target price increased by Mizuho from $55.00 to $65.00. The firm currently has an outperform rating on the stock.
Inspire Medical Systems (NYSE:INSP) had its target price boosted by JPMorgan Chase & Co. from $54.00 to $60.00. The firm currently has a neutral rating on the stock.
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target boosted by JPMorgan Chase & Co. from $265.00 to $276.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Lithia Motors (NYSE:LAD) had its target price boosted by JPMorgan Chase & Co. from $325.00 to $340.00. The firm currently has a neutral rating on the stock.
Marriott International (NASDAQ:MAR) had its price target cut by Mizuho from $384.00 to $374.00. The firm currently has a neutral rating on the stock.
Matson (NYSE:MATX) had its target price boosted by JPMorgan Chase & Co. from $230.00 to $270.00. They currently have an overweight rating on the stock.
MasTec (NYSE:MTZ) had its target price lowered by Mizuho from $502.00 to $457.00. Mizuho currently has an outperform rating on the stock.
Northern Trust (NASDAQ:NTRS) had its target price boosted by JPMorgan Chase & Co. from $179.50 to $185.50. The firm currently has a neutral rating on the stock.
onsemi (NASDAQ:ON) had its target price reduced by Mizuho from $125.00 to $110.00. They currently have an outperform rating on the stock.
Penske Automotive Group (NYSE:PAG) had its price target raised by JPMorgan Chase & Co. from $170.00 to $215.00. The firm currently has a neutral rating on the stock.
Phillips Edison & Company, Inc. (NASDAQ:PECO) had its target price increased by JPMorgan Chase & Co. from $41.00 to $46.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Progressive (NYSE:PGR) had its target price trimmed by JPMorgan Chase & Co. from $250.00 to $241.00. They currently have a neutral rating on the stock.
Sonic Automotive (NYSE:SAH) had its price target cut by JPMorgan Chase & Co. from $76.00 to $72.00. They currently have an underweight rating on the stock.
SBA Communications (NASDAQ:SBAC) had its price target cut by JPMorgan Chase & Co. from $230.00 to $220.00. The firm currently has a neutral rating on the stock.
State Street (NYSE:STT) had its target price boosted by JPMorgan Chase & Co. from $176.50 to $187.00. The firm currently has a neutral rating on the stock.
United Dominion Realty Trust (NYSE:UDR) had its price target raised by JPMorgan Chase & Co. from $39.00 to $41.00. They currently have an underweight rating on the stock.
Valero Energy (NYSE:VLO) had its target price boosted by Mizuho from $289.00 to $300.00. Mizuho currently has a neutral rating on the stock.
WAVE Life Sciences (NASDAQ:WVE) had its target price trimmed by Mizuho from $27.00 to $23.00. Mizuho currently has an outperform rating on the stock.
Receive News & Ratings for Asbury Automotive Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asbury Automotive Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.
